Literature DB >> 16859895

Estimating the prevalence of schizophrenia in Spain using a disease model.

J L Ayuso-Mateos1, P Gutierrez-Recacha, J M Haro, D Chisholm.   

Abstract

There are two main sources of information on the epidemiology of schizophrenia: prevalence and incidence studies. Prevalence rates can be estimated from incidence figures, and vice versa. The present article aims to provide an estimate of the prevalence of schizophrenia in Spain, calculated from epidemiological and demographic data, using a disease model of schizophrenia which applies the specific methodology of the WHO Global Burden of Disease project. Our model assumes a causal relationship between incidence and prevalence, but takes into account other competing risk factors of mortality; this approach is more realistic than one assuming a simple linear relationship between both parameters. Our findings indicate an estimated mean prevalence of 3.0 per 1000 inhabitants per year for men, but slightly lower for women: 2.86 per 1000. Our model enables us to compare incidence figures with those provided by prevalence studies and obtain accurate estimates of the distribution of schizophrenia in the general population, which can be used to better identify treatment needs and the consequent allocation of resources.

Entities:  

Mesh:

Year:  2006        PMID: 16859895     DOI: 10.1016/j.schres.2006.06.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Trends on schizophrenia admissions during the deinstitutionalisation process in Spain (1980-2004).

Authors:  Zuleika Saz-Parkinson; A Medel; P Cediel-García; J Castellote; C Bouza; J M Amate
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-10-24       Impact factor: 4.328

2.  Relationship between incidence and prevalence in psychotic disorders: An incidence-prevalence-mortality model.

Authors:  Baptiste Pignon; Franck Schürhoff; Grégoire Baudin; Andrea Tortelli; Aziz Ferchiou; Ghassen Saba; Jean-Romain Richard; Antoine Pelissolo; Marion Leboyer; Andrei Szöke
Journal:  Int J Methods Psychiatr Res       Date:  2018-05-22       Impact factor: 4.035

3.  [Health among persons with intellectual disability in Spain: the European POMONA-II study].

Authors:  Rafael Martínez-Leal; Luis Salvador-Carulla; Mencía Ruiz Gutiérrez-Colosía; Margarida Nadal; Ramón Novell-Alsina; Almudena Martorell; Rodrigo G González-Gordón; M Reyes Mérida-Gutiérrez; Silvia Ángel; Luisa Milagrosa-Tejonero; Alicia Rodríguez; Juan C García-Gutiérrez; Amado Pérez-Vicente; José García-Ibáñez; Francisco Aguilera-Inés
Journal:  Rev Neurol       Date:  2011-10-01       Impact factor: 0.870

4.  Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study.

Authors:  Juan Antonio García-Carmona; Jorge Simal-Aguado; María Pilar Campos-Navarro; Francisco Valdivia-Muñoz; Alejandro Galindo-Tovar
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

5.  Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Authors:  Dan Chisholm; Oye Gureje; Sandra Saldivia; Marcelo Villalón Calderón; Rajitha Wickremasinghe; Nalaka Mendis; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

6.  Prevalence of schizophrenia and related disorders in Malaga (Spain): results using multiple clinical databases.

Authors:  B Moreno-Küstner; F Mayoral; D Navas-Campaña; J M García-Herrera; P Angona; C Martín; F Rivas
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-15       Impact factor: 6.892

Review 7.  A family affair: brain abnormalities in siblings of patients with schizophrenia.

Authors:  Marcel E Moran; Hilleke Hulshoff Pol; Nitin Gogtay
Journal:  Brain       Date:  2013-05-22       Impact factor: 13.501

8.  Schizophrenia in Thailand: prevalence and burden of disease.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram; Pichet Udomratn
Journal:  Popul Health Metr       Date:  2010-08-17

9.  Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison.

Authors:  Tatiana Dilla; Jörgen Möller; Paul O'Donohoe; María Álvarez; José A Sacristán; Michael Happich; Antje Tockhorn
Journal:  BMC Psychiatry       Date:  2014-12-02       Impact factor: 3.630

10.  Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.

Authors:  C F M G van Kesteren; H Gremmels; L D de Witte; E M Hol; A R Van Gool; P G Falkai; R S Kahn; I E C Sommer
Journal:  Transl Psychiatry       Date:  2017-03-28       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.